Pharma, not high-tech, concerns now dominate US patent politics

0



The first pronouncements from new USPTO Director Kathi Vidal are the latest indication that the centre of gravity in IP debate and policy-making has shifted significantly



Source link

Leave A Reply

Your email address will not be published.